Become an Investor
Triple Hair wants to create value for our investors through the launch of innovative hair loss solutions based on specific patient needs. After a successful phase II proof of concept of our prescription product TH07, Triple Hair is currently in the process of starting a phase III trial and is looking for funding to complete all the regulatory requirements before going to market.
Triple Hair is aiming to successfully launch the first hair loss prescription product since Propecia in 1997 and become a key player in the $8.5B global hair loss market.
GLOBAL: US$8.5 billion
NORTH AMERICA: US$3.9 billion
GLOBAL PROJECTED: US$12.4 billion (in 2025)
Source: Grand View Research 2019
TAKE THE NEXT STEP
Want to invest and become a key contributor
in the most promising hair loss dedicated biotech company?
Fill out the form below and we'll contact you.